Mon, Jul 28, 2014, 4:06 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Inovio Pharmaceuticals, Inc. Message Board

  • schoir schoir Jan 25, 2012 2:58 PM Flag

    Clinical Trials

    Results from this follow on study are due in March. Positive results could further spur an upword climb. http://clinicaltrials.gov/ct2/show/NCT01403155?term=inovio&rank=6

    PHASE I, OPEN-LABEL, SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF AN H5 INFLUENZA PLASMID VACCINE (INO-3401) IN HEALTHY ADULTS PREVIOUSLY VACCINATED WITH VGX-3400X

    Another possible source of new is Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity in Healthy Adult Males of a DNA Plasmid Vaccine for HS Avian Influenza (VGX-3400) Administered by Intramuscular (IM) Injection Followed by Electroporation (EP)with a completion date is February 2012.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INO
11.88-0.75(-5.94%)4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.